Weekly paclitaxel and carboplatin with concurrent radiation therapy in locally advanced non-small cell lung cancer: Phase I study

Radiation Medicine - Medical Imaging and Radiation Oncology

Volumn 23, Issue 5, 2005, Pages 331-335

  Endo, Masahiro ^a,b   Takada, Yoshiki ^b   Obayashi, Kayoko ^b   Kotani, Yoshikazu ^b   Satouchi, Miyako ^b   Kado, Tetsuharu ^b   Sugimura, Kazuro ^c  

^a SHIZUOKA CITY SHIMIZU HOSPITAL   (Japan)

^b HYOGO MEDICAL CENTER FOR ADULTS   (Japan)

^c KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Carboplatin; Chemoradiation therapy; Non small cell lung cancer; Paclitaxel; Phase I study

Indexed keywords

CARBOPLATIN; PACLITAXEL;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ESOPHAGITIS; FEMALE; HEART ARRHYTHMIA; HUMAN; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; MALE; NAUSEA AND VOMITING; NEUTROPENIA; RADIATION DOSE; RADIATION PNEUMONIA; THROMBOCYTOPENIA;

ADULT; AGED; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CARCINOMA, NON-SMALL-CELL LUNG; COHORT STUDIES; COMBINED MODALITY THERAPY; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; HEMODYNAMIC PROCESSES; HUMANS; LUNG NEOPLASMS; MALE; MAXIMUM TOLERATED DOSE; MIDDLE AGED; PACLITAXEL;

EID: 24644511753     PISSN: 02882043     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Dillman RO, Seagren SL, Propert KJ, et al. A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small-cell lung cancer. N Engl J Med, 323: 940-945, 1990.
2. LeChevalier T, Arriagada R, Quoix E, et al. Radiotherapy alone versus combined chemotherapy and radiotherapy in nonresectable non-small-cell lung cancer: first analysis of a randomized trial in 353 patients. J Natl Cancer Inst, 83: 417-423, 1991.
3. Schaake-Koning C, van den Bogaert W, Dalesio O, et al. Effects of concomitant cisplatin and radiotherapy on inoperable non-small-cell lung cancer. N Engl J Med, 326: 524-530, 1992.
4. Sause WT, Scott C, Taylor S, et al. Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: preliminary results of a phase III trial in regionally advanced non-small-cell lung cancer. J Natl Cancer Inst, 87: 198-205, 1995.
5. Dillman RO, Herndon J, Seagren SL, Eaton WL Jr, Green MR. Improved survival in stage III non-small-cell lung cancer: seven-year follow-up of cancer and leukemia group B (CALGB) 8433 trial. J Natl Cancer Inst, 88: 1210-1215, 1996.
6. Choy H, Safran H. Preliminary analysis of a phase II study of weekly paclitaxel and concurrent radiation therapy for locally advanced non-small-cell lung cancer. Semin Oncol, 22 (4 Suppl 9) 22: 55-57, 1995.
7. Furuse K, Fukuoka M, Kawahara M, et al. Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer. J Clin Oncol, 17: 2692-2699, 1999.
8. Solomon B, Ball DL, Richardson G, et al. Phase I/II study of concurrent twice-weekly paclitaxel and weekly cisplatin with radiation therapy for stage III non-small cell lung cancer. Lung Cancer, 41: 353-361, 2003.
9. Johnson DH, Paul DM, Hande KR, et al. Paclitaxel plus carboplatin in advanced non-small-cell lung cancer: a phase II trial. J Clin Oncol, 14: 2054-2060, 1996.
10. Choy H, Rodriguez FF, Koester S, Hilsenbeck S, Von Hoff DD. Investigation of taxol as a potential radiation sensitizer. Cancer, 71: 3774-3778, 1993.
11. Choy H, Browne MJ. Paclitaxel as a radiation sensitizer in non-small cell lung cancer. Semin Oncol, (3 Suppl 6) 22: 70-74, 1995.
12. Choy H, Akerley W, Safran H, et al. Phase I trial of outpatient weekly paclitaxel and concurrent radiation therapy for advanced non-small-cell lung cancer. J Clin Oncol, 12: 2682-2686, 1994.
13. Choy H, Akerley W, Safran H, et al. Multiinstitutional phase II trial of paclitaxel, carboplatin, and concurrent radiation therapy for locally advanced non-small-cell lung cancer. J Clin Oncol, 16: 3316-3322, 1998.
14. Douple EB, Richmond RC, O'Hara JA, Coughlin CT. Carboplatin as a potentiator of radiation therapy. Cancer Treat Rev, 12 (Suppl A): 111-124, 1985.
15. Amorino GP, Hamilton VM, Choy H. Enhancement of radiation effects by combined docetaxel and carboplatin treatment in vitro. Radiat Oncol Investig, 1: 343-352, 1999.
16. Mountain CF. The international system for staging lung cancer. Semin Surg Oncol, 18: 106-115, 2000.
17. Calvert AH, Newell DR, Gumbrell LA, et al. Carboplatin dosage: prospective evaluation of a simple formula based on renal function. J Clin Oncol, 7: 1748-1756, 1989.
18. Acute radiation morbidity scoring criteria. Available at http://www.rtog.org/members/toxicity.acute.html